TRxADE HEALTH Inc. (MEDS) Financial Statements (2025 and earlier)
Company Profile
| Business Address |
2420 BRUNELLO TRACE LUTZ, FL 33558 |
| State of Incorp. | DE |
| Fiscal Year End | December 31 |
| Industry (SIC) | 2834 - Pharmaceutical Preparations (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)
| 9/30/2024 MRQ | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments | 152 | 1,134 | 3,123 | 5,920 | 2,872 | 870 | |||
| Cash and cash equivalents | 152 | 1,134 | 3,123 | 5,920 | 2,872 | 870 | |||
| Receivables | 2,122 | 729 | 979 | 805 | 792 | 434 | |||
| Inventory, net of allowances, customer advances and progress billings | 1 | 120 | 56 | 1,258 | 57 | 80 | |||
| Inventory | 1 | 120 | 56 | 1,258 | 57 | 80 | |||
| Prepaid expense | 108 | 111 | 216 | 151 | 82 | 83 | |||
| Deferred costs | |||||||||
| Disposal group, including discontinued operation | |||||||||
| Other undisclosed current assets | 371 | 1,088 | |||||||
| Total current assets: | 2,753 | 2,093 | 4,374 | 9,221 | 3,803 | 1,466 | |||
| Noncurrent Assets | |||||||||
| Operating lease, right-of-use asset | 530 | 1,052 | 1,233 | 387 | 758 | ✕ | |||
| Property, plant and equipment | 277 | 65 | 99 | 162 | 175 | 15 | |||
| Long-term investments and receivables | |||||||||
| Long-term investments | |||||||||
| Intangible assets, net (including goodwill), including: | 8,963 | 451 | 726 | 726 | |||||
| Goodwill | 726 | 726 | |||||||
| Intangible assets, net (excluding goodwill) | 8,963 | ||||||||
| Other undisclosed intangible assets, net (including goodwill) | 451 | ||||||||
| Deposits noncurrent assets | 11 | 49 | 60 | 22 | 22 | 21 | |||
| Deferred costs | 88 | ||||||||
| Total noncurrent assets: | 9,780 | 1,617 | 1,392 | 571 | 1,769 | 762 | |||
| TOTAL ASSETS: | 12,533 | 3,710 | 5,766 | 9,793 | 5,571 | 2,228 | |||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities | 2,483 | 1,019 | 747 | 476 | 433 | 539 | |||
| Accounts payable | 2,082 | 729 | 477 | 257 | 335 | 401 | |||
| Accrued liabilities | 401 | 290 | 270 | 219 | 99 | 138 | |||
| Deferred revenue | 10 | ✕ | |||||||
| Debt | 6,530 | 87 | 182 | ||||||
| Disposal group, including discontinued operation | |||||||||
| Other liabilities | 70 | 68 | |||||||
| Due to related parties | ✕ | ✕ | 167 | 225 | |||||
| Other undisclosed current liabilities | 2,473 | 893 | 179 | 131 | 140 | ||||
| Total current liabilities: | 11,556 | 2,147 | 926 | 842 | 521 | 860 | |||
| Noncurrent Liabilities | |||||||||
| Long-term debt and lease obligation | 25 | 1,070 | 271 | 685 | |||||
| Long-term debt, excluding current maturities | 25 | ||||||||
| Liabilities, other than long-term debt | 409 | 1,220 | 225 | 523 | |||||
| Due to related parties | ✕ | ✕ | 333 | 225 | 523 | ||||
| Other liabilities | 887 | ||||||||
| Operating lease, liability | 409 | 1,070 | 271 | 685 | ✕ | ||||
| Other undisclosed noncurrent liabilities | (1,070) | (271) | |||||||
| Total noncurrent liabilities: | 434 | 1,220 | 1,070 | 271 | 910 | 523 | |||
| Total liabilities: | 11,991 | 3,367 | 1,996 | 1,114 | 1,431 | 1,383 | |||
| Equity | |||||||||
| Equity, attributable to parent | 542 | 763 | 3,770 | 8,679 | 4,140 | 845 | |||
| Common stock | 0 | 0 | 0 | 0 | 0 | 0 | |||
| Additional paid in capital | 33,788 | 20,483 | 20,018 | 19,611 | 12,536 | 8,955 | |||
| Accumulated deficit | (33,246) | (19,720) | (16,247) | (10,932) | (8,396) | (8,111) | |||
| Equity, attributable to noncontrolling interest | (420) | ||||||||
| Total equity: | 542 | 343 | 3,770 | 8,679 | 4,140 | 845 | |||
| TOTAL LIABILITIES AND EQUITY: | 12,533 | 3,710 | 5,766 | 9,793 | 5,571 | 2,228 | |||
Income Statement (P&L) ($ in thousands)
| 9/30/2024 TTM | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | ||
|---|---|---|---|---|---|---|---|---|
| Revenues | 8,272 | 11,448 | 9,889 | 17,123 | 7,436 | 3,832 | ||
| Cost of revenue (Cost of Goods and Services Sold) | (5,674) | (5,997) | (5,143) | (11,415) | (2,566) | (449) | ||
| Gross profit: | 2,598 | 5,451 | 4,746 | 5,707 | 4,871 | 3,383 | ||
| Operating expenses | (9,862) | (9,876) | (10,038) | (8,214) | (4,746) | (3,473) | ||
| Other undisclosed operating income | 2 | |||||||
| Operating income (loss): | (7,263) | (4,424) | (5,292) | (2,507) | 125 | (88) | ||
| Nonoperating income (expense) | (6,457) | 514 | (178) | 162 | ||||
| Investment income, nonoperating | (250) | |||||||
| Other nonoperating income | 15 | 21 | 72 | 162 | ||||
| Interest and debt expense | (1,198) | (336) | (24) | (29) | (232) | (65) | ||
| Income (loss) from continuing operations before equity method investments, income taxes: | (14,919) | (4,246) | (5,316) | (2,536) | (284) | 9 | ||
| Loss from equity method investments | (250) | |||||||
| Income (loss) from continuing operations before income taxes: | (14,919) | (4,246) | (5,316) | (2,536) | (534) | 9 | ||
| Other undisclosed income from continuing operations | ||||||||
| Income (loss) from continuing operations: | (14,919) | (4,246) | (5,316) | (2,536) | (534) | 9 | ||
| Income (loss) before gain (loss) on sale of properties: | ✕ | ✕ | ✕ | (5,316) | (2,536) | (534) | 9 | |
| Income (loss) from discontinued operations | (4,123) | |||||||
| Other undisclosed net income | 1,198 | 336 | 250 | |||||
| Net income (loss): | (17,844) | (3,910) | (5,316) | (2,536) | (284) | 9 | ||
| Net income attributable to noncontrolling interest | 438 | |||||||
| Net income (loss) available to common stockholders, diluted: | (17,844) | (3,472) | (5,316) | (2,536) | (284) | 9 | ||
Comprehensive Income ($ in thousands)
| 9/30/2024 TTM | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | ||
|---|---|---|---|---|---|---|---|---|
| Net income (loss): | (17,844) | (3,910) | (5,316) | (2,536) | (284) | 9 | ||
| Comprehensive income (loss): | (17,844) | (3,910) | (5,316) | (2,536) | (284) | 9 | ||
| Comprehensive income, net of tax, attributable to noncontrolling interest | 438 | |||||||
| Comprehensive income (loss), net of tax, attributable to parent: | (17,844) | (3,472) | (5,316) | (2,536) | (284) | 9 | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.